ETV6 and acute lymphoblastic leukemia: Combining whole-exome discovery in familial ALLs and targeted sequencing in a large frontline national clinical trials (N=4,405), we comprehensively identified a panel of 31 ETV6 germline variants that were likely associated with ALL risk.